A phase II trial of sequential ribonucleotide reductase inhibition in aggressive myeloproliferative neoplasms

Myeloproliferative neoplasms are a varied group of disorders that can have prolonged chronic phases, but eventually accelerate and can transform into a secondary acute myeloid leukemia that is ultimately fatal. Triapine is a novel inhibitor of the M2 subunit of ribonucleotide reductase. Sequential i...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Zeidner, Joshua F., Karp, Judith E., Blackford, Amanda L., Smith, B. Douglas, Gojo, Ivana, Gore, Steven D., Levis, Mark J., Carraway, Hetty E., Greer, Jacqueline M., Ivy, S. Percy, Pratz, Keith W., McDevitt, Michael A.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Ferrata Storti Foundation 2014
Aiheet:
Articles
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3971077/
https://ncbi.nlm.nih.gov/pubmed/24362550
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2013.097246
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia